Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-01-08 @ 4:15 PM
Study NCT ID:
NCT00054405
Status:
TERMINATED
Last Update Posted:
2013-04-09
First Post:
2003-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma
Sponsor:
National Cancer Institute (NCI)